Diaceutics (7DC) Ratios
Diaceutics Ratios
DE:7DC's free cash flow for Q2 2026 was $3.40M. For the 2026 fiscal year, DE:7DC's free cash flow was decreased by $-21.00K and operating cash flow was $3.42M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.43 | 3.80 | 6.40 | 8.23 | 11.41 |
| Quick Ratio | 3.43 | 3.80 | 6.40 | 8.23 | 11.41 |
| Cash Ratio | 0.86 | 1.64 | 3.80 | 5.29 | 7.47 |
| Solvency Ratio | 0.62 | 0.33 | 0.54 | 0.65 | 0.54 |
| Operating Cash Flow Ratio | 0.17 | 0.08 | 0.30 | 1.37 | 0.22 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 41.52 | 4.38 |
| Net Current Asset Value | $ 19.83M | $ 20.77M | $ 22.48M | $ 25.15M | $ 25.70M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 |
| Debt-to-Equity Ratio | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 |
| Debt-to-Capital Ratio | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.24 | 1.22 | 1.14 | 1.14 | 1.11 |
| Debt Service Coverage Ratio | 102.33 | 55.15 | 46.23 | 15.32 | 11.23 |
| Interest Coverage Ratio | 4.59 | -45.46 | -45.73 | 4.71 | 6.25 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 |
| Net Debt to EBITDA | -1.02 | -4.21 | -6.55 | -5.13 | -7.71 |
| Profitability Margins | |||||
| Gross Profit Margin | 67.97% | 87.91% | 83.15% | 71.97% | 75.78% |
| EBIT Margin | 0.69% | -5.77% | -10.19% | 3.08% | 3.94% |
| EBITDA Margin | 15.81% | 8.62% | 9.95% | 18.50% | 16.85% |
| Operating Profit Margin | 0.69% | -7.63% | -12.73% | 2.95% | 3.94% |
| Pretax Profit Margin | 0.62% | -5.93% | -10.29% | 2.89% | 3.31% |
| Net Profit Margin | 0.25% | -5.30% | -7.37% | 3.71% | 4.02% |
| Continuous Operations Profit Margin | 0.25% | -5.30% | -7.37% | 3.71% | 4.02% |
| Net Income Per EBT | 40.42% | 89.26% | 71.62% | 128.37% | 121.43% |
| EBT Per EBIT | 90.23% | 77.72% | 80.78% | 98.09% | 84.00% |
| Return on Assets (ROA) | 0.19% | -3.50% | -3.77% | 1.50% | 1.25% |
| Return on Equity (ROE) | 0.24% | -4.27% | -4.28% | 1.70% | 1.38% |
| Return on Capital Employed (ROCE) | 0.64% | -6.01% | -7.19% | 1.29% | 1.30% |
| Return on Invested Capital (ROIC) | 0.26% | -5.34% | -5.13% | 1.28% | 1.29% |
| Return on Tangible Assets | 0.29% | -5.13% | -5.62% | 2.19% | 1.74% |
| Earnings Yield | 0.09% | -1.61% | -2.38% | 1.14% | 0.66% |
| Efficiency Ratios | |||||
| Receivables Turnover | 1.83 | 2.15 | 2.34 | 1.87 | 1.40 |
| Payables Turnover | 8.01 | 3.19 | 3.75 | 7.20 | 6.58 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 23.10 | 19.16 | 12.48 | 9.32 | 6.55 |
| Asset Turnover | 0.77 | 0.66 | 0.51 | 0.40 | 0.31 |
| Working Capital Turnover Ratio | 1.81 | 1.42 | 0.93 | 0.71 | 0.48 |
| Cash Conversion Cycle | 153.56 | 55.56 | 58.60 | 144.46 | 205.21 |
| Days of Sales Outstanding | 199.12 | 169.81 | 155.96 | 195.13 | 260.65 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 45.56 | 114.25 | 97.35 | 50.67 | 55.45 |
| Operating Cycle | 199.12 | 169.81 | 155.96 | 195.13 | 260.65 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.02 | 0.01 | 0.02 | 0.06 | 0.01 |
| Free Cash Flow Per Share | 0.02 | -0.05 | -0.04 | 0.00 | -0.06 |
| Dividend Paid and CapEx Coverage Ratio | 21.07 | 0.14 | 0.27 | 1.06 | 0.10 |
| Capital Expenditure Coverage Ratio | 21.07 | 0.14 | 0.27 | 1.06 | 0.10 |
| Operating Cash Flow Coverage Ratio | 1.30 | 0.61 | 1.09 | 3.87 | 0.37 |
| Operating Cash Flow to Sales Ratio | 0.04 | 0.02 | 0.06 | 0.26 | 0.04 |
| Free Cash Flow Yield | 1.32% | -3.76% | -4.84% | 0.44% | -5.88% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 1163.64 | -62.24 | -41.97 | 87.75 | 152.61 |
| Price-to-Sales (P/S) Ratio | 2.82 | 3.30 | 3.09 | 3.26 | 6.14 |
| Price-to-Book (P/B) Ratio | 2.67 | 2.66 | 1.80 | 1.49 | 2.11 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 75.98 | -26.62 | -20.68 | 228.54 | -17.02 |
| Price-to-Operating Cash Flow Ratio | 72.37 | 162.81 | 55.89 | 12.34 | 150.20 |
| Price-to-Earnings Growth (PEG) Ratio | -11.04 | 25.77 | 0.12 | 3.09 | 1.57 |
| Enterprise Value Multiple | 16.79 | 34.01 | 24.51 | 12.48 | 28.74 |
| Enterprise Value | 102.07M | 94.31M | 57.82M | 45.02M | 67.50M |
| EV to EBITDA | 16.79 | 34.01 | 24.51 | 12.48 | 28.74 |
| EV to Sales | 2.66 | 2.93 | 2.44 | 2.31 | 4.84 |
| EV to Free Cash Flow | 71.63 | -23.69 | -16.31 | 161.95 | -13.42 |
| EV to Operating Cash Flow | 68.23 | 144.86 | 44.10 | 8.75 | 118.42 |
| Tangible Book Value Per Share | 0.29 | 0.29 | 0.30 | 0.32 | 0.33 |
| Shareholders’ Equity Per Share | 0.48 | 0.47 | 0.48 | 0.51 | 0.48 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.60 | 0.11 | 0.28 | -0.28 | -0.21 |
| Revenue Per Share | 0.45 | 0.38 | 0.28 | 0.23 | 0.17 |
| Net Income Per Share | 0.00 | -0.02 | -0.02 | 0.01 | 0.01 |
| Tax Burden | 0.40 | 0.89 | 0.72 | 1.28 | 1.21 |
| Interest Burden | 0.90 | 1.03 | 1.01 | 0.94 | 0.84 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.82 | 0.96 | 0.96 | 0.83 | 0.85 |
| Stock-Based Compensation to Revenue | 0.02 | 0.03 | 0.02 | 0.03 | 0.03 |
| Income Quality | 15.42 | -0.34 | -0.75 | 7.11 | 1.02 |
Currency in GBP